Cited 0 times in
Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 라선영 | - |
dc.date.accessioned | 2025-02-03T08:48:03Z | - |
dc.date.available | 2025-02-03T08:48:03Z | - |
dc.date.issued | 2024-02 | - |
dc.identifier.issn | 1470-2045 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/201876 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Lancet Pub. Group | - |
dc.relation.isPartOf | LANCET ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Antibodies, Monoclonal, Humanized / adverse effects | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols / adverse effects | - |
dc.subject.MESH | Carcinoma, Non-Small-Cell Lung* / drug therapy | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lung Neoplasms* / drug therapy | - |
dc.subject.MESH | Stomach Neoplasms* / drug therapy | - |
dc.title | Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sun Young Rha | - |
dc.contributor.googleauthor | Sonal Bordia | - |
dc.identifier.doi | 10.1016/S1470-2045(24)00022-6 | - |
dc.contributor.localId | A01316 | - |
dc.relation.journalcode | J02154 | - |
dc.identifier.eissn | 1474-5488 | - |
dc.identifier.pmid | 38301694 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1470204524000226 | - |
dc.contributor.alternativeName | Rha, Sun Young | - |
dc.contributor.affiliatedAuthor | 라선영 | - |
dc.citation.volume | 25 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | e52 | - |
dc.identifier.bibliographicCitation | LANCET ONCOLOGY, Vol.25(2) : e52, 2024-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.